These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1879975)

  • 1. Spontaneous rosetting of human T lymphocytes with breast cancer cells.
    Kennett R; Seth R; Makgoba MW
    Int J Cancer; 1991 Sep; 49(2):317-9. PubMed ID: 1879975
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428.
    Sanders ME; Makgoba MW; Sussman EH; Luce GE; Cossman J; Shaw S
    Cancer Res; 1988 Jan; 48(1):37-40. PubMed ID: 3275493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Martin E. Sanders et al., Molecular Pathways of Adhesion in Spontaneous Rosetting of T-Lymphocytes to the Hodgkin's Cell Line L428.
    Flavell DJ; Wright DH
    Cancer Res; 1990 May; 50(10):3131-2. PubMed ID: 2334908
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of breast tumor antigen-sensitive circulating T-lymphocytes by antigen-stimulated active rosette formation.
    Ramey WG; Hashim GA; Burrows WB; Swistel AJ; Munther A; Fitzpatrick HF
    Cancer Res; 1979 Dec; 39(12):4796-801. PubMed ID: 315272
    [No Abstract]   [Full Text] [Related]  

  • 5. Ferritin and depressed lymphocytes in breast cancer.
    Whitehead RH; Roberts GP; Worwood M
    N Engl J Med; 1978 Feb; 298(5):280. PubMed ID: 304178
    [No Abstract]   [Full Text] [Related]  

  • 6. T-cell markers in breast cancer patients at diagnosis.
    Goust JM; Roof BS; Fudenberg HH; O'Brien PH
    Clin Immunol Immunopathol; 1979 Apr; 12(4):396-403. PubMed ID: 313292
    [No Abstract]   [Full Text] [Related]  

  • 7. Importance of methodology in demonstrating depression of T-lymphocyte levels.
    Whitehead RH; Roberts GP; Hughes LE; Thatcher J
    Br J Cancer; 1978 Jan; 37(1):28-32. PubMed ID: 304356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-rosette inhibition and tumour recurrence in early breast cancer.
    Haffejee AA; Webster DJ; Paterson AG; Whitehead RH; Thatcher J; Hughes LE; Angorn IB
    Br J Surg; 1983 Jun; 70(6):319-21. PubMed ID: 6602641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of sheep red blood cell rosetting for human T cells: gain of reactivity to mitogenic factors.
    Larsson EL; Andersson J; Coutinho A
    Eur J Immunol; 1978 Oct; 8(10):693-6. PubMed ID: 309393
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the mechanism of T-cell depression following radiotherapy or surgery for stage III breast cancer.
    Shukla HS; Whitehead RH; Hughes LE
    Clin Oncol; 1980 Mar; 6(1):39-47. PubMed ID: 6966205
    [No Abstract]   [Full Text] [Related]  

  • 11. T and B lymphocytes in cancer patients.
    Sengupta U; Dutta TK; Gupta BD; Aikat BK
    Indian J Cancer; 1978 Jun; 15(2):6-9. PubMed ID: 312245
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of T-cell population in carcinoma breast.
    Nirwan PS; Ramdeo IN; Solanki RL
    Indian J Cancer; 1980 Dec; 17(4):210-5. PubMed ID: 6262220
    [No Abstract]   [Full Text] [Related]  

  • 13. Human T cell rosetting is mediated by LFA-3 on autologous erythrocytes.
    Makgoba MW; Shaw S; Gugel EA; Sanders ME
    J Immunol; 1987 Jun; 138(11):3587-9. PubMed ID: 3108368
    [No Abstract]   [Full Text] [Related]  

  • 14. Spontaneous rosetting characteristics of prostaglandin (PG)-treated lymphocytes from patients with solid neoplasias.
    Misefari A; Venza-Teti D; Teti G; La Via MF; Rust PF
    Clin Immunol Immunopathol; 1981 Jan; 18(1):85-94. PubMed ID: 7193103
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of circulating lung tumor antigen-sensitive T lymphocytes in the early stages of lung cancer.
    Ramey WG; Hashim GA; Munther AS; Swistel AJ; Burrows WB; Fitzpatrick HF
    Surgery; 1980 Aug; 88(2):202-7. PubMed ID: 6967233
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating human T cell subset with a reversible E-rossetting capacity in cancer and normals-hypothesis on the regulatory mechanism influencing their role in CMI.
    Moroz C; Kupfer B; Giler S
    Adv Exp Med Biol; 1979; 114():733-8. PubMed ID: 313689
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphoproliferative responses to mouse mammary tumor virus in lymphocyte subsets of breast cancer patients.
    Lopez DM; Parks WP; Silverman MA; Distasio JA
    J Natl Cancer Inst; 1981 Aug; 67(2):353-8. PubMed ID: 6267344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between T lymphocyte levels and lymphoproliferative responses to mitogens and alloantigens in lung and breast cancer patients.
    Jerrells TR; Dean JH; Herberman RB
    Int J Cancer; 1978 Mar; 21(3):282-90. PubMed ID: 305421
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppressor cel activity of ferritin-bearing lymphocytes in patients with breast cancer.
    Moroz C; Kupfer B
    Isr J Med Sci; 1981; 17(9-10):879-81. PubMed ID: 6458580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thymosin on T-lymphocyte rosette formation in Nigerian patients with different types of cancer.
    Olusi SO; Oluwole SF; Odesanmi WO
    Afr J Med Med Sci; 1984; 13(3-4):103-9. PubMed ID: 6099969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.